United States — Startups · corporate

Investor Backed Out After Signing Term Sheet: What to Do in United States Startups

Having an investor walk away after signing a term sheet leaves founders facing depleted cash runway and lost deal momentum after turning away other capital under exclusivity. While core investment terms in venture term sheets are generally non-binding under United States corporate law, ancillary provisions—such as exclusivity, confidentiality, and legal expense reimbursement—remain legally enforceable. Understanding your rights under Delaware law and standard National Venture Capital Association (NVCA) provisions allows you to release exclusivity immediately, stop mounting legal bills, and protect your company.

Share WhatsAppFacebookXLinkedInEmail

The rules are the same for everybody, but what you should do depends on your dates, your documents, and what the other side has said. On Caunsel you write down what's actually going on and get answers about your situation, with the law they rely on, or just talk it through out loud. If it needs follow-up, you keep it as a case, and when there's paperwork, it'll suggest what you need, write it up, and you can e-sign it right there.

What the Law Says About Signed Term Sheets in United States Startups

In United States startup practice—predominantly governed by Delaware corporate and contract law—a signed term sheet is almost always bifurcated into binding and non-binding sections. Following standards popularized by the National Venture Capital Association (NVCA), the core investment terms (such as valuation, investment amount, liquidation preferences, and board seats) are expressly designated as non-binding. Because these are merely preliminary frameworks for future definitive agreements, courts will not grant specific performance to force an investor to wire money or close the round.

However, term sheets are not meaningless paper. The signature page typically specifies that select sections—most notably Exclusivity (No-Shop), Confidentiality, Governing Law, and Expenses—are legally binding obligations upon execution. Furthermore, under Delaware law, preliminary agreements carry legal consequences if they require the parties to negotiate in good faith. In the landmark decision SIGA Technologies, Inc. v. PharmAthene, Inc., 67 A.3d 330 (Del. 2013), the Delaware Supreme Court held that an express obligation to negotiate in good faith in accordance with a preliminary term sheet is enforceable; a party that acts in bad faith by walking away or demanding terms contrary to the term sheet may be held liable for contract expectation damages if a deal would have closed but for that bad faith.

Despite SIGA, most venture term sheets contain explicit disclaimers stating that neither party is bound to consummate the financing, and investors frequently cite due diligence findings as their commercial rationale for walking away. Because litigation against venture capital firms can be cost-prohibitive and carry reputational fallout, your practical legal leverage focuses on enforcing binding termination rights, shielding confidential trade secrets, and rejecting unjustified fee demands.

Enforcing Binding Covenants: Exclusivity and Expense Allocation

The most immediate legal trap for a startup after an investor withdraws is the exclusivity or 'no-shop' clause. If your term sheet binds the company to negotiate exclusively with the investor for 30 to 60 days, you cannot simply begin circulating pitch decks to new venture funds the next morning without triggering potential breach-of-contract claims. You must secure a formal, written termination of discussions that explicitly extinguishes the exclusivity obligation and releases your company to solicit alternative capital.

Next, examine the expense reimbursement clause. Venture capital term sheets frequently include a provision requiring the startup to pay the investor's outside legal counsel fees, often capped at a specific dollar amount (e.g., $25,000 to $40,000). Standard NVCA-style language dictates that this reimbursement is payable 'at the Closing.' If your term sheet conditions legal fees on a successful closing, you are generally not obligated to pay the investor's legal bills when they pull out unilaterally. If the clause was poorly drafted and purports to apply regardless of closing, an attorney should review whether the investor's withdrawal constitutes a failure of condition or breach of good faith.

What You Can Do Next to Protect Your Runway and Rights

Your priority must shift from shock to clinical damage control. Immediately audit and terminate access to your virtual data room, revoking permissions for the investor's partners, associates, and outside counsel. Because the confidentiality covenant in the term sheet remains legally binding on both parties, issue a formal written notice reminding the investor of their ongoing obligation to maintain the confidentiality of your proprietary metrics, customer lists, and financial projections.

Do not sign any broad mutual release or separation letter presented by the departing investor without legal scrutiny. Investors sometimes offer quick 'clean-break' paperwork that releases them from any potential confidentiality or bad-faith claims while quietly preserving their right to reimbursement or intellectual property protections. You can use Caunsel to research term sheet enforceability, save your deal correspondence and drafts in a secure case file, or connect with an independent corporate lawyer to evaluate your exposure and clear your path to new financing.

Steps

These are the general steps. Caunsel works out which ones apply to you, with your dates and documents.

Get help for my business

Common mistakes

Questions people ask

Can a startup sue an investor for backing out after signing a term sheet under US law?

Directly forcing the investor to fund the round is generally impossible because the valuation and capital commitments are explicitly non-binding. While Delaware law (SIGA Technologies v. PharmAthene) allows lawsuits for breach of an express agreement to negotiate in good faith, establishing that the investor walked away in bad faith rather than over genuine diligence findings is a steep evidentiary burden, and venture litigation is rarely commercially practical for early-stage companies.

Are we still bound by the exclusivity (no-shop) clause if the investor stopped responding?

Yes, unless the term sheet contains an automatic termination trigger upon abandonment or the stated time window has elapsed. Until the term sheet expires or you receive written confirmation terminating discussions, pitching other leads can technically violate the contract. You must issue formal notice demanding confirmation of deal termination to dissolve the restriction cleanly.

Do we have to reimburse the investor's legal fees if the deal dies?

Under standard NVCA venture templates, company reimbursement of the investor's legal expenses is contingent upon the closing of the financing. Unless your term sheet explicitly contains 'broken deal' language requiring reimbursement regardless of whether the transaction closes, you typically do not have to pay the departing investor's counsel.

Ask Caunsel or an independent corporate lawyer to review your signed term sheet's expense and exclusivity clauses to ensure you can legally re-engage alternative investors without liability.

Research it with the advisor, keep documents in a case, or talk to an independent lawyer. Start a subscription for AI tools.

Know someone dealing with this? Send them this guide.

Share WhatsAppFacebookXLinkedInEmail

General information only, last updated 2026-11-17. Caunsel is not a law firm and does not practise law. AI answers and this guide are not legal advice. Verify filings, deadlines, and statutes with a licensed lawyer in United States — Startups.